1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow ctDNA Biopsy Panel: new trials by email Literature Review of ctDNA Biopsy Panel trials Research Report on ctDNA Biopsy Panel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLC Osimertinib, Cyclosporine A (CsA), ctDNA Biopsy Panel - Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor | Phase 2 | Recruiting | NYU Langone Health | 60 | 2026-10-01 | 2026-10-15 |
Carcinoma, Non-Small-Cell Lung (1)
United States (1)
Elaine Shum, MD (1)